ESR1 and breast carcinoma: As ERα36 fails to interact with E2 (26), the association of GPER with the ERα36 residues 123-139 may explain how E2 participates, albeit indirectly, in the ERα36-dependent transcriptional machinery, and why tamoxifen is mitogenic in ERα-negative breast cancer cells (29).